The use of nomegestrol acetate in rapid preparation of endometrium before operative hysteroscopy in pre-menopausal women

Steroids

Volumn 75, Issue 12, 2010, Pages 912-917

  Florio, Pasquale ^a   Imperatore, Alberto ^a   Litta, Pietro ^b   Franchini, Mario ^c   Calzolari, Stefano ^c   Angioni, Stefano ^d   Gabbanini, Massimo ^a   Bruni, Luca ^a   Petraglia, Felice ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c Palagi Freestanding Unit   (Italy)

^d UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Endometrium; HPA axis; Hysteroscopy; Progestins; Surgery

Indexed keywords

ESTRADIOL; FOLANEMIN; FOLIC ACID; FOLLITROPIN; LUTEINIZING HORMONE; NOMEGESTROL ACETATE; PLACEBO; PROGESTERONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; ECHOGRAPHY; ENDOMETRIUM; ENDOMETRIUM BIOPSY; ENDOMETRIUM POLYP; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILE PERIOD; FOLLITROPIN BLOOD LEVEL; HEADACHE; HUMAN; HYSTEROSCOPY; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; MUCOSA; NAUSEA; OPERATION DURATION; OPERATIVE HYSTEROSCOPY; OVARY FOLLICLE; POSTOPERATIVE COMPLICATION; PREMENOPAUSE; PROGESTERONE BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SWELLING; THICKNESS; TRANSVAGINAL ECHOGRAPHY; TREATMENT DURATION; TREATMENT RESPONSE;

ADMINISTRATION, ORAL; ADULT; ENDOMETRIUM; FEMALE; HUMANS; HYSTEROSCOPY; MEGESTROL; NORPREGNADIENES; POLYPS; PREMENOPAUSE; TIME FACTORS;

EID: 77955926973     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2010.05.009     Document Type: Article

References (26)

1. C. Sutton Hysteroscopic surgery Best Pract Res Clin Obstet Gynaecol 20 2006 105 137
2. J. Bosteels, S. Weyers, P. Puttemans, C. Panayotidis, B. Van Herendael, and V. Gomel The effectiveness of hysteroscopy in improving pregnancy rates in subfertile women without other gynaecological symptoms: a systematic review Hum Reprod Update 16 2010 1 11
3. A. Di Spiezio Sardo, I. Mazzon, S. Bramante, S. Bettocchi, G. Bifulco, and M. Guida Hysteroscopic myomectomy: a comprehensive review of surgical techniques Hum Reprod Update 14 2008 101 119
4. S.R. Goldstein The role of transvaginal ultrasound or endometrial biopsy in the evaluation of the menopausal endometrium Am J Obstet Gynecol 201 2009 5 11
5. V.S. Rai, M.D. Gillmer, and W. Gray Is endometrial pre-treatment of value in improving the outcome of transcervical resection of the endometrium? Hum Reprod 15 2000 1989 1992
6. P. Vercellini, A. Perino, R. Consonni, L. Trespidi, F. Parazzini, and P.G. Crosignani Treatment with a gonadotrophin releasing hormone agonist before endometrial resection: a multicentre, randomised controlled trial Br J Obstet Gynaecol 103 1996 562 568
7. J. Donnez, G. Vilos, M.J. Gannon, S. Stampe-Sorensen, I. Klinte, and R.M. Miller Goserelin acetate (Zoladex) plus endometrial ablation for dysfunctional uterine bleeding: a large randomized, double-blind study Fertil Steril 68 1997 29 36
8. F. Parazzini, P. Vercellini, O. De Giorgi, A. Pesole, E. Ricci, and P.G. Crosignani Efficacy of pre-operative medical treatment in facilitating hysteroscopic endometrial resection, myomectomy and metroplasty: literature review Hum Reprod 13 1998 2592 2597
9. M.C. Sowter, A. Lethaby, and A.A. Singla Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding Cochrane Database Syst Rev 3 2002 CD001124
10. R. Sitruk-Ware New progestagens for contraceptive use Hum Reprod Update 12 2006 169 178
11. R. Sitruk-Ware Pharmacological profile of progestins Maturitas 47 2004 277 283
12. R. Sitruk-Ware New progestogens: a review of their effects in perimenopausal and postmenopausal women Drugs Aging 21 2004 865 883
13. C. Kluft Effects of hormone treatment on hemostasis variables Climacteric 10 2007 32 37
14. J.R. Pasqualini Progestins in the menopause in healthy women and breast cancer patients Maturitas 62 2009 343 348
15. S.J. Pocok, and R. Simon Sequential assignment with balancing for prognostic factors in the controlled clinical trial Biometrics 31 1975 103 215
16. R.W. Noyes, A.T. Hertig, and J. Rock Dating the endometrial biopsy Am J Obstet Gynecol 122 1975 262 263
17. M.S. Baggish, and J. Barbot Contact hysteroscopy Clin Obstet Gynecol 26 1983 219 241
18. H. Kuhl Comparative pharmacology of newer progestogens Drugs 51 1996 188 215
19. J. Catherino Nomegestrol acetate, a clinically useful 19-norprogesterone derivative which lacks estrogenic activity J Steroid Biochem Mol Biol 55 1995 239 246
20. J. Shields-Botella, I. Duc, E. Duranti, F. Puccio, P. Bonnet, and R. Delansorne An overview of nomegestrol acetate selective receptor binding and lack of estrogenic action on hormone-dependent cancer cells J Steroid Biochem Mol Biol 87 2003 111 122
21. J. Botella, E. Duranti, V. Viader, I. Duc, R. Delansorne, and J. Paris Lack of estrogenic potential of progesterone- or 19-nor-progesterone-derived progestins as opposed to testosterone or 19-nor-testosterone derivatives on endometrial Ishikawa cells J Steroid Biochem Mol Biol 55 1995 77 84
22. G. Chetrite, J. Paris, J. Botella, and J.R. Pasqualini Effect of nomegestrol acetate on estrone sulfatase and 17b-hydroxysteroid dehydrogenase activities in human breast cancer cells J Steroid Biochem Mol Biol 58 1996 525 531
23. G.S. Chetrite, J.L. Thomas, J. Shields-Botella, J. Cortes-Prieto, J.C. Philippe, and J.R. Pasqualini Control of sulfatase activity by nomegestrol acetate in the normal and cancerous human breast tissues Anticancer Res 25 2005 2827 2830
24. J. Botella, E. Duranti, I. Duc, A.M. Cognet, R. Delansorne, and J. Paris Inhibition by nomegestrol acetate and other synthetic progestins on proliferation and progesterone receptor content of T47-D human breast cancer cells J Steroid Biochem Mol Biol 50 1994 41 47
25. J. Shields-Botella, G. Chetrite, S. Meschi, and J.R. Pasqualini Effect of nomegestrol acetate on estrogen biosynthesis and transformation in MCF-7 and T47-D breast cancer cells J Steroid Biochem Mol Biol 93 2005 1 13
26. B. Couzinet, J. Young, S. Brailly, P. Chanson, J.L. Thomas, and G. Schaison The anti-gonadotropic activity of progestins (19-nortestosterone and 19-norprogesterone derivatives) is not mediated through the androgen receptor J Clin Endocrinol Metab 81 1996 4218 4223